Univariate | Multivariate | |||
---|---|---|---|---|
HR (95% CI) | P value | HR(95% CI) | P value | |
Sex | ||||
Male | Reference | 1.00 | Reference | 1.00 |
Female | 1.334 (1.055–1.686) | 0.016* | 1.215 (0.958–1.540) | 0.108 |
Rash | ||||
Yes | Reference | 1.00 | Reference | 1.00 |
No | 1.295 (1.019–1.645) | 0.035* | 0.976 (0.761–1.251) | 0.846 |
IVIG treatment | ||||
Not delayed | Reference | 1.00 | Reference | 1.00 |
Delayed | 0.672 (0.515–0.875) | 0.022* | 0.722 (0.550–0.950) | 0.020* |
CAL type | ||||
Single | Reference | 1.00 | Reference | 1.00 |
Multiple | 0.382 (0.294–0.496) | <0.001* | 0.516 (0.392–0.677) | <0.001* |
Degree of CAL | ||||
Only dilation | Reference | 1.00 | Reference | 1.00 |
Aneurysm | 0.246 (0.158–0.382) | <0.001* | 0.319 (0.202–0.505) | <0.001* |
Laboratory data | ||||
White blood cell count before IVIG | 0.979 (0.962–0.997) | 0.019 | 1.004 (0.981–1.020) | 0.971 |
Platelet count after IVIG | 0.999 (0.998–0.999) | 0.003 | 0.9992 (0.9986–0.9998) | 0.007* |